Doctor profile · Federal record
Dr. Neil Palmisiano, MD
Medical Oncology Physician (CMS: Medical Oncology) · Internal Medicine Physician · Hematology (Internal Medicine) Physician · Hematology (Internal Medicine) Physician · Medical Oncology Physician · Philadelphia, PA
- NPI 1306007505
- Accepts Medicare
- 12 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
925 Chestnut St, Suite 320A
Philadelphia, PA 191074216
(215) 955-8874
fax (215) 955-2340 - Additional location
-
900 Medical Center Dr Ste 201
Sewell, NJ 080802358
(856) 577-7900
Credentials & registration
- NPI registered
- June 2008 — 18 yrs on file
- Profile last updated
- May 3, 2024
- Year of graduation
- 2014 — 12 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State licenses (2)
- New Jersey #25MA10344300 · Pennsylvania #MD443799
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1306007505. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
228
Distinct HCPCS
3
Medicare allowed
$31,474
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 122 | 25 | $126 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 85 | 37 | $144 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 21 | 20 | $186 |
In context: peer comparison
Among 48 peers in this city , average services per provider: 121. This provider delivers 1.9× the peer median.Open Payments
Industry payments received
All-time total
$5,660
Transactions
9
Manufacturers
3
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 5 | $4,340.00 | |
| Novartis Pharmaceuticals Corporation | 3 | $1,184.79 | |
| AstraZeneca Pharmaceuticals LP | 1 | $135.00 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
238
Patients
37
Total drug cost
$2,882,987
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Venclexta (Venetoclax) | Brand | 52 | 20 | $417,476 |
| Azacitidine | Generic | 33 | 0 | $13,157 |
| Acyclovir | Generic | 29 | 17 | $503 |
| Sprycel (Dasatinib) | Brand | 24 | 0 | $283,830 |
| Onureg (Azacitidine) | Brand | 21 | 0 | $542,448 |
| Iclusig (Ponatinib Hcl) | Brand | 20 | 0 | $540,458 |
| Tasigna (Nilotinib Hcl) | Brand | 17 | 0 | $334,585 |
| Xospata (Gilteritinib Fumarate) | Brand | 16 | 0 | $368,849 |
| Imbruvica (Ibrutinib) | Brand | 13 | 0 | $225,135 |
| Rydapt (Midostaurin) | Brand | 13 | 0 | $156,546 |
Hospital affiliations
Frequently asked questions
What is Dr. Neil Palmisiano's medical specialty?
Dr. Neil Palmisiano practices Medical Oncology Physician in Philadelphia, PA.
Where does Dr. Neil Palmisiano practice?
Dr. Neil Palmisiano practices at 925 Chestnut St, Philadelphia, PA 191074216. Office phone: 2159558874.
What is Dr. Neil Palmisiano's NPI?
Dr. Neil Palmisiano's National Provider Identifier (NPI) is 1306007505, issued by NPPES.
Does Dr. Neil Palmisiano accept Medicare assignment?
Yes. Dr. Neil Palmisiano accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Neil Palmisiano commonly perform?
Top Medicare-reported procedures in 2023: Subsequent hospital care with moderate levelof medical decision making (HCPCS 99233); Established patient office or other outpatient visit (HCPCS 99215); Initial hospital care with moderate level of medical decision making (HCPCS 99223). Source: CMS Medicare Physician & Other Practitioners file.